Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (DRKS00041513) titled 'Real-World Application Study to Evaluate the Use, Acceptance, and Perceived Benefits of the Medical Device FEMANEA Among Women with Stress and Mixed Incontinence' on Sept. 3.
Study Type: observational
Study Design:
Allocation:
Masking:
Control:
Assignment:
Study design purpose: treatment
Primary Sponsor: PrehApp GmbH
Condition:
N39.3
Stress incontinence
Intervention:
Group 1: Observation group: FEMANEA users (single-arm study, no control group) receive a one-time final questionnaire after 90 days of using FEMANEA, in which their experiences with the product are assessed.
Recruitment Status: Not Recruiting
...